Credit Agreements in the Biotechnology Industry

369 Contracts & Agreements

Browse by Company

AbbVie Inc. (9 contracts)
ACHIEVE LIFE SCIENCES, INC. (3)
ADiTx Therapeutics, Inc. (9)
ADMA BIOLOGICS, INC. (15)
AKCEA THERAPEUTICS, INC. (1)
Akebia Therapeutics, Inc. (2)
Alexion Pharmaceuticals (6)
Alkermes plc. (3)
Alliqua BioMedical, Inc. (5)
ALNYLAM PHARMACEUTICALS, INC. (2)
ALX ONCOLOGY HOLDINGS INC (1)
Amgen Inc. (9)
AMICUS THERAPEUTICS, INC. (2)
AmpliPhi Biosciences Corp (3)
Anika Therapeutics (3)
Aptevo Therapeutics Inc. (6)
ARCA biopharma, Inc. (1)
Arcturus Therapeutics Holdings Inc. (2)
Athenex, Inc. (10)
ATOSSA GENETICS INC (2)
AZIYO BIOLOGICS, INC. (6)
BIOCRYST PHARMACEUTICALS INC (2)
Biogen Inc. (5)
Biohaven Pharmaceutical Holding Co Ltd. (1)
BIOMARIN PHARMACEUTICAL INC (2)
BIOTIME INC (10)
C4 Therapeutics, Inc. (2)
CANCER GENETICS, INC (14)
CareDx, Inc. (4)
CATABASIS PHARMACEUTICALS INC (1)
Cellular Biomedicine Group, Inc. (4)
Coherus BioSciences, Inc. (2)
CURIS INC (6)
Dermira, Inc. (1)
Eagle Pharmaceuticals, Inc. (1)
Emerald Bioscience, Inc. (5)
Emergent BioSolutions Inc. (8)
Epizyme, Inc. (1)
EXICURE, INC. (4)
Fibrocell Science, Inc. (1)
Flexion Therapeutics Inc (5)
Fortress Biotech, Inc. (6)
GALECTIN THERAPEUTICS INC (4)
Gilead Sciences (3)
Gossamer Bio, Inc. (5)
HALOZYME THERAPEUTICS INC (4)
HARBOR DIVERSIFIED, INC. (7)
HUMANIGEN, INC (2)
iBio, Inc. (5)
INFINITY PHARMACEUTICALS, INC. (1)
Inmune Bio, Inc. (1)
INOVIO PHARMACEUTICALS, INC. (1)
INSMED Inc (1)
Invitae Corp (4)
IONIS PHARMACEUTICALS INC (1)
IRONWOOD PHARMACEUTICALS INC (5)
Kadmon Holdings, Inc. (8)
Kura Oncology, Inc. (1)
MANNKIND CORP (4)
MEDICINOVA INC (1)
MeiraGTx Holdings plc (1)
MERRIMACK PHARMACEUTICALS INC (1)
MiMedx Group, Inc. (4)
Molecular Templates, Inc. (3)
Myriad Genetics, Inc. (2)
Natera, Inc. (3)
NEUROCRINE BIOSCIENCES INC (2)
Nuo Therapeutics, Inc. (3)
Opko Health, Inc. (13)
ORAGENICS INC (3)
Orgenesis Inc. (5)
Oyster Point Pharma, Inc. (1)
PDL BIOPHARMA, INC. (10)
Pfenex Inc. (7)
PORTOLA PHARMACEUTICALS INC (2)
PROGENITY, INC. (6)
PTC THERAPEUTICS, INC. (7)
RECURSION PHARMACEUTICALS, INC. (1)
Regeneron Pharmaceuticals (7)
Retrophin, Inc. (6)
Rezolute, Inc. (2)
RIGEL PHARMACEUTICALS INC (3)
Sarepta Therapeutics, Inc. (4)
Seres Therapeutics, Inc. (1)
Sorrento Therapeutics, Inc. (4)
Spectrum Pharmaceuticals, Inc. (2)
Synthetic Biologics, Inc. (2)
TG THERAPEUTICS, INC. (3)
United Therapeutics Corp (5)
VBI Vaccines Inc (6)
VERACYTE, INC. (1)
Verastem, Inc. (1)
Vertex Pharmaceuticals Inc (3)
WINDTREE THERAPEUTICS INC (2)

Recent Contracts

Sixth Amendment, dated September 18, 2023, to the Credit Agreement by and between iBio CDMO LLC and Woodforest National Bank (iBio, Inc., Filed With SEC on September 21, 2023)
Credit Agreement, dated as of August 28, 2023 among Biogen Inc., JPMorgan Chase Bank N.A., as administrative agent and the other lenders party thereto (Biogen Inc., Filed With SEC on September 1, 2023)
Consent and Amendment to Amended and Restated Note Purchase Agreement and Guaranty, dated August 10, 2023, by and among MeiraGTx Holdings plc, as issuer, the subsidiary guarantors... (MeiraGTx Holdings plc, Filed With SEC on August 10, 2023)
CREDIT AGREEMENT (Arcturus Therapeutics Holdings Inc., Filed With SEC on August 7, 2023)
REVOLVING LINE OF CREDIT NOTE (Arcturus Therapeutics Holdings Inc., Filed With SEC on August 7, 2023)
Credit and Security Agreement, dated July 10, 2023 (AmpliPhi Biosciences Corp, Filed With SEC on July 11, 2023)
First Amendment to Secured Convertible Credit and Security Agreement (AmpliPhi Biosciences Corp, Filed With SEC on July 11, 2023)
First Amendment, dated as of May 12, 2023, to the Credit Agreement, dated August 10, 2022, by and among Aziyo Biologics, Inc., SWK Funding LLC, as Agent and the Lenders from time... (AZIYO BIOLOGICS, INC., Filed With SEC on May 12, 2023)
Amendment No. 2 to the Credit Agreement (HALOZYME THERAPEUTICS INC, Filed With SEC on May 9, 2023)
Warrant Agreement, dated March 31, 2023, by and between TG Therapeutics, Inc. and Hercules Private Credit Fund 1 L.P (TG THERAPEUTICS, INC., Filed With SEC on May 8, 2023)
Amended and Restated Warrant Agreement, dated March 31, 2023, by and between TG Therapeutics, Inc. and Hercules Private Credit Fund 1 L.P (TG THERAPEUTICS, INC., Filed With SEC on May 8, 2023)
Amendment No. 2 to the Credit and Guaranty Agreement, dated as of May 1, 2023 (ADMA BIOLOGICS, INC., Filed With SEC on May 2, 2023)
Credit Agreement and Guaranty, dated April 27, 2023, among Seres Therapeutics, Inc., a Delaware corporation, as the borrower, the subsidiary guarantors from time to time party... (Seres Therapeutics, Inc., Filed With SEC on April 27, 2023)
Second Amended and Restated Revolving Credit Agreement, dated as of March 28, 2023, among AbbVie, the lenders and other parties party thereto and JPMorgan Chase Bank, N.A., as... (AbbVie Inc., Filed With SEC on March 28, 2023)
Amendment No. 1 to Credit Agreement and Guaranty, dated March 23, 2023 by and among the Company, Hayfin Services LLP and the lenders party thereto (ADMA BIOLOGICS, INC., Filed With SEC on March 23, 2023)
Fourth Amendment to Credit, Guarantee and Security Agreement, dated February 14, 2023, by and among the Registrant, GB001, Inc., GB002, Inc. and GB004, Inc., as co-borrowers, the... (Gossamer Bio, Inc., Filed With SEC on March 17, 2023)
Third Amendment to Credit, Guarant (Gossamer Bio, Inc., Filed With SEC on March 17, 2023)
Third Amended and Restated Credit Agreement, dated as of March 9, 2023, among Amgen Inc., the Banks therein named, Citibank, N.A., as Administrative Agent, and JPMorgan Chase... (Amgen Inc., Filed With SEC on March 9, 2023)
Amendment No. 8 to Credit and Security Agreement, dated November 3, 2021, by and among MannKind Corporation, MannKind LLC, QrumPharma, Inc., and MidCap Financial Trust (MANNKIND CORP, Filed With SEC on February 23, 2023)
Amendment No. 9 to Credit and Security Agreement, dated November 8, 2021, by and among MannKind Corporation, MannKind LLC, QrumPharma, Inc., and MidCap Financial Trust (MANNKIND CORP, Filed With SEC on February 23, 2023)
Third Amendment to Credit Agreement dated February 21, 2023 between iBio CDMO LLC and Woodforest National Bank and Third Amended Guaranty of iBio, Inc (iBio, Inc., Filed With SEC on February 21, 2023)
Second Amendment to Credit Agreement dated February 9, 2023 by and between iBio, Inc. and Woodforest National Bank (iBio, Inc., Filed With SEC on February 14, 2023)
Convertible Credit Line and Unsecured Convertible Note Extension #2 Agreement, dated as of January 12, 2023, by and between the Company and Yosef Dotan (Orgenesis Inc., Filed With SEC on January 18, 2023)
Convertible Credit Line Extension Agreement, dated as of January 12, 2023, by and between the Company and Aharon Lukach (Orgenesis Inc., Filed With SEC on January 18, 2023)
Secured Convertible Credit and Security Agreement, dated January 10, 2023 (AmpliPhi Biosciences Corp, Filed With SEC on January 10, 2023)
Amendment No. 5 to Multi Draw Credit Agreement, dated December 30, 2022, by and between the Company and Sciences (Emerald Bioscience, Inc., Filed With SEC on January 6, 2023)
Credit Agreement, dated as of December 19, 2022, by and among Regeneron Pharmaceuticals, Inc., as a borrower and guarantor; certain direct subsidiaries of Regeneron... (Regeneron Pharmaceuticals, Filed With SEC on December 20, 2022)
Bridge Credit Agreement, dated as of December 12, 2022, by and among Amgen Inc., Citibank, N.A., as administrative agent, Bank of America, N.A., as syndication agent, Citibank,... (Amgen Inc., Filed With SEC on December 12, 2022)
Amendment Letter, dated as of November 30, 2022, to the Credit Agreement, dated as of August 10, 2022, among Aziyo Biologics, Inc., SWK Funding LLC, as Agent, and the Lenders from... (AZIYO BIOLOGICS, INC., Filed With SEC on December 5, 2022)
Amendment Letter, dated as of November 21, 2022, to the Credit Agreement, dated as of August 10, 2022, among Aziyo Biologics, Inc., SWK Funding LLC, as Agent, and the Lenders from... (AZIYO BIOLOGICS, INC., Filed With SEC on November 28, 2022)
Waiver to Credit and Guaranty Agreement, by and among Athenex, Inc., the Lenders party thereto, and Oaktree Fund Administration, LLC, as administrative agent for the Lenders,... (Athenex, Inc., Filed With SEC on November 21, 2022)
Amendment Letter, dated as of November 10, 2022 to Credit Agreement, dated as of August 10, 2022, between Aziyo Biologics, Inc. and SWK Funding LLC, as Agent and the Lenders from... (AZIYO BIOLOGICS, INC., Filed With SEC on November 14, 2022)
Third Amendment to Credit and Security Agreement dated August 30, 2022 (Aptevo Therapeutics Inc., Filed With SEC on November 10, 2022)
Amendment No. 10 to the Credit and Security Agreement, dated August 29, 2022, by and among MannKind Corporation, MannKind LLC, QrumPharma, Inc., and MidCap Financial Trust (MANNKIND CORP, Filed With SEC on November 8, 2022)
Revenue Interest Purchase Agreement, dated October 19, 2022, between Insmed Incorporated and OrbiMed Royalty & Credit Opportunities III, LP (INSMED Inc, Filed With SEC on October 27, 2022)
Amendment Letter to Credit Agreement, dated as of October 9, 2022, between Aziyo Biologics, Inc. and SWK Funding LLC, as Agent and a Lender (AZIYO BIOLOGICS, INC., Filed With SEC on October 13, 2022)
First Amendment to Credit Agreement entered into as of October 11, 2022 by and between iBio CDMO LLC with Woodforest National Ban (iBio, Inc., Filed With SEC on October 11, 2022)
Amendment No. 1 to the Credit Agreement (HALOZYME THERAPEUTICS INC, Filed With SEC on August 19, 2022)
Sixth Amendment to Credit and Guaranty Agreement, by and among Athenex, Inc., the Lenders party thereto, and Oaktree Fund Administration, LLC, as administrative agent for the... (Athenex, Inc., Filed With SEC on August 18, 2022)
Credit Agreement, dated as of August 10, 2022, between Aziyo Biologics, Inc. and the subsidiaries of the Company, with the financial institutions party thereto from time to time... (AZIYO BIOLOGICS, INC., Filed With SEC on August 15, 2022)